These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35372012)

  • 41. A seven-long noncoding RNA signature predicts relapse in patients with early-stage lung adenocarcinoma.
    Zhou H; Zhang H; Chen J; Cao J; Liu L; Guo C; Huang G; Zeng D
    J Cell Biochem; 2019 Sep; 120(9):15730-15739. PubMed ID: 31050375
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of a Genomic Instability-Derived lncRNAs-Based Risk Signature as a Predictor of Prognosis for Endometrial Cancer.
    Wang X; Ye L; Li B
    J Cancer; 2022; 13(7):2213-2225. PubMed ID: 35517417
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Seven-Long Non-coding RNA Signature Improves Prognosis Prediction of Lung Adenocarcinoma: An Integrated Competing Endogenous RNA Network Analysis.
    Li R; Han K; Xu D; Chen X; Lan S; Liao Y; Sun S; Rao S
    Front Genet; 2020; 11():625977. PubMed ID: 33584817
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of a Genomic Instability-Related Long Noncoding RNA Prognostic Model in Colorectal Cancer Based on Bioinformatic Analysis.
    Liang Y; Sun HX; Ma B; Meng QK
    Dis Markers; 2022; 2022():4556585. PubMed ID: 35711569
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Construction of subtype classifiers and validation of a prognostic risk model based on hypoxia-associated lncRNAs for lung adenocarcinoma.
    Hui H; Li D; Lin Y; Miao H; Zhang Y; Li H; Qiu F; Jiang B
    J Thorac Dis; 2023 Jul; 15(7):3919-3933. PubMed ID: 37559652
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Six mutator-derived lncRNA signature of genome instability for predicting the clinical outcome of colon cancer.
    Chen S; Li X; Zhang J; Li L; Wang X; Zhu Y; Guo L; Wang J
    J Gastrointest Oncol; 2021 Oct; 12(5):2157-2171. PubMed ID: 34790382
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Four long noncoding RNAs act as biomarkers in lung adenocarcinoma.
    Zhang Z; Yang L; Li Y; Wu Y; Li X; Wu X
    Open Med (Wars); 2021; 16(1):660-671. PubMed ID: 33981850
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of a Somatic Mutation-Derived Long Non-Coding RNA Signatures of Genomic Instability in Renal Cell Carcinoma.
    Fang X; Liu X; Lu L; Liu G
    Front Oncol; 2021; 11():728181. PubMed ID: 34676164
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Novel Model Based on Genomic Instability-Associated Long Non-Coding RNAs for Predicting Prognosis and Response to Immunotherapy in Patients With Lung Adenocarcinoma.
    Tu G; Peng W; Cai Q; Zhao Z; Peng X; He B; Zhang P; Shi S; Wang X
    Front Genet; 2021; 12():720013. PubMed ID: 34777461
    [No Abstract]   [Full Text] [Related]  

  • 50. Identification of a Genome Instability-Associated LncRNA Signature for Prognosis Prediction in Colon Cancer.
    Yin T; Zhao D; Yao S
    Front Genet; 2021; 12():679150. PubMed ID: 34163531
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genome Instability-Associated Long Non-Coding RNAs Reveal Biomarkers for Glioma Immunotherapy and Prognosis.
    Wang X; Zhang H; Ye J; Gao M; Jiang Q; Zhao T; Wang S; Mao W; Wang K; Wang Q; Chen X; Hou X; Han D
    Front Genet; 2022; 13():850888. PubMed ID: 35571034
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An Immune-Related lncRNA Expression Profile to Improve Prognosis Prediction for Lung Adenocarcinoma: From Bioinformatics to Clinical Word.
    Zhang B; Wang R; Li K; Peng Z; Liu D; Zhang Y; Zhou L
    Front Oncol; 2021; 11():671341. PubMed ID: 33968781
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Establishing a Prognostic Model Based on Three Genomic Instability-related LncRNAs for Clear Cell Renal Cell Cancer.
    Lulu S; Hualing H; Shan Z; Dianxi C; Yiqing L; Qin L
    Clin Genitourin Cancer; 2022 Aug; 20(4):e317-e329. PubMed ID: 35321833
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of an immune-related six-long noncoding RNA signature as a novel prognosis biomarker for adenocarcinoma of lung.
    Miao H; Chen D; Li R; Hu J; Chen Y; Xu C; Wen Z
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33324975
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of ceRNA network based on a RNA-seq shows prognostic lncRNA biomarkers in human lung adenocarcinoma.
    Li X; Li B; Ran P; Wang L
    Oncol Lett; 2018 Nov; 16(5):5697-5708. PubMed ID: 30344725
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An efficient five-lncRNA signature for lung adenocarcinoma prognosis, with AL606489.1 showing sexual dimorphism.
    Liang J; Jin W; Xu H
    Front Genet; 2022; 13():1052092. PubMed ID: 36531243
    [No Abstract]   [Full Text] [Related]  

  • 57. Relationships of N6-Methyladenosine-Related Long Non-Coding RNAs With Tumor Immune Microenvironment and Clinical Prognosis in Lung Adenocarcinoma.
    Zhao J; Lin X; Zhuang J; He F
    Front Genet; 2021; 12():714697. PubMed ID: 34777460
    [No Abstract]   [Full Text] [Related]  

  • 58. Identification and Validation of a Novel Immune-Related Four-lncRNA Signature for Lung Adenocarcinoma.
    Wang J; Yin X; Zhang YQ; Ji X
    Front Genet; 2021; 12():639254. PubMed ID: 33708243
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immune landscape and a promising immune prognostic model associated with TP53 in early-stage lung adenocarcinoma.
    Wu C; Rao X; Lin W
    Cancer Med; 2021 Feb; 10(3):806-823. PubMed ID: 33314730
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long non-coding RNAs correlate with genomic stability in prostate cancer: A clinical outcome and survival analysis.
    Jianfeng W; Yutao W; Jianbin B
    Genomics; 2021 Sep; 113(5):3141-3151. PubMed ID: 34174340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.